Yu H - Search Results

1

The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H. Lu L, et al. Among authors: yu h. Clin Cancer Res. 2006 Feb 15;12(4):1208-14. doi: 10.1158/1078-0432.CCR-05-1801. Clin Cancer Res. 2006. PMID: 16489075

2

Insulin-like growth factors and breast cancer risk in Chinese women.

Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W. Yu H, et al. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):705-12. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12163322

3

Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.

Yu H, Shu XO, Li BD, Dai Q, Gao YT, Jin F, Zheng W. Yu H, et al. Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1067-73. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14578144

4

Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma.

Malin A, Dai Q, Yu H, Shu XO, Jin F, Gao YT, Zheng W. Malin A, et al. Among authors: yu h. Cancer. 2004 Feb 15;100(4):694-700. doi: 10.1002/cncr.20023. Cancer. 2004. PMID: 14770423 Free PMC article.

5

IGF-I and breast cancer: a meta-analysis.

Shi R, Yu H, McLarty J, Glass J. Shi R, et al. Among authors: yu h. Int J Cancer. 2004 Sep 1;111(3):418-23. doi: 10.1002/ijc.20233. Int J Cancer. 2004. PMID: 15221971

6

Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women.

Wen W, Gao YT, Shu XO, Yu H, Cai Q, Smith JR, Zheng W. Wen W, et al. Among authors: yu h. Int J Cancer. 2005 Jan 10;113(2):307-11. doi: 10.1002/ijc.20571. Int J Cancer. 2005. PMID: 15386404

7

Insulin-like growth factor-I, soy protein intake, and breast cancer risk.

Sanderson M, Shu XO, Yu H, Dai Q, Malin AS, Gao YT, Zheng W. Sanderson M, et al. Among authors: yu h. Nutr Cancer. 2004;50(1):8-15. doi: 10.1207/s15327914nc5001_2. Nutr Cancer. 2004. PMID: 15572292

8

Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings.

Tran N, Bharaj BS, Diamandis EP, Smith M, Li BD, Yu H. Tran N, et al. Among authors: yu h. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2133-40. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598771

9

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.

Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H. Wiley A, et al. Among authors: yu h. Cancer. 2006 Jul 15;107(2):299-308. doi: 10.1002/cncr.21992. Cancer. 2006. PMID: 16773633 Free article.

10

Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H. Lu L, et al. Among authors: yu h. Gynecol Oncol. 2006 Dec;103(3):990-5. doi: 10.1016/j.ygyno.2006.06.006. Epub 2006 Jul 21. Gynecol Oncol. 2006. PMID: 16859738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,566 results

Search Page

Filters